Manu Chaudhary
About
In The Last Decade
Manu Chaudhary
61 papers receiving 342 citations
Peers
Comparison fields: 5 of 92
- Molecular Medicine 193
- Pharmacology 153
- Epidemiology 94
- Molecular Biology 88
- Applied Microbiology and Biotechnology 79
Countries citing papers authored by Manu Chaudhary
This map shows the geographic impact of Manu Chaudhary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manu Chaudhary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manu Chaudhary more than expected).
Fields of papers citing papers by Manu Chaudhary
This network shows the impact of papers produced by Manu Chaudhary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manu Chaudhary. The network helps show where Manu Chaudhary may publish in the future.
Co-authorship network of co-authors of Manu Chaudhary
This figure shows the co-authorship network connecting the top 25 collaborators of Manu Chaudhary. A scholar is included among the top collaborators of Manu Chaudhary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manu Chaudhary. Manu Chaudhary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 11 | |
| 4 | EVALUATION OF EZENUS IN AN EXPERIMENTAL MODEL OF DIET-INDUCED ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER CONDITION IN RATS | 1 |
| 5 | Comparison of Antioxidant Potential of Ezenus Versus Marketed Herbal Products in India: an In-vitro Study | 1 |
| 6 | 1 | |
| 7 | Comparative efficacy of antibiotics in biofilms eradication formed by ESBL andnon ESBL producing micro-organisms | 6 |
| 8 | Sulbactomax prevents antimicrobial resistance development byinhibition of conjugal transfer of F plasmids | 1 |
| 9 | Catering ESBL resistance challenge through strategic combination ofCeftriaxone, Sulbactam and Ethylenediaminetetraacetic Acid | 2 |
| 10 | Comparative Safety Evaluation of Potentox® Vs Co-Administration of Cefepime And Amikacin In Healthy Albino Rat | 0 |
| 11 | A comparative study of Sulbactomax versus Ceftriaxone andbetalactamase inhibitor and their effect on mutant prevention in ESBL producing organisms | 1 |
| 12 | 1 | |
| 13 | ACUTE DERMAL TOXICITY STUDIES OF TROISTM IN NEWZEALANDWHITE RABBITS | 3 |
| 14 | EFFICACY EVALUATION OF AMPUCARE IN COMPARISON WITHSILVER SULFADIAZINE IN BURN WOUND HEALING IN RATS. | 1 |
| 15 | Sub Acute Toxicity of Aceclofenac Drug in Albino Rat | 1 |
| 16 | 8 | |
| 17 | 18 | |
| 18 | 8 | |
| 19 | 18 | |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.